Insulin glargine and lixisenatide Subcutaneous and Ipratropium and Albuterol
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Ipratropium and Albuterol and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: albuterol / ipratropium
Brand name: Combivent Respimat, DuoNeb, Combivent
Synonyms: Albuterol and ipratropium (inhalation)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Ipratropium and Albuterol Inhalation Solution
- Insulin glargine and lixisenatide Subcutaneous-Ipratropium and Albuterol Inhalation Spray
- Insulin glargine and lixisenatide Subcutaneous-Ipratropium and albuterol Inhalation, oral/nebulization
- Insulin glargine and lixisenatide Subcutaneous-Ipratropium Bromide
- Insulin glargine and lixisenatide Subcutaneous-Ipratropium Bromide eent
- Insulin glargine and lixisenatide Subcutaneous-Ipratropium Bromide Nebuamp
- Ipratropium and Albuterol-Insulin glargine, recombinant Subcutaneous
- Ipratropium and Albuterol-Insulin glulisine
- Ipratropium and Albuterol-Insulin Glulisine (Cartridges and Pens)
- Ipratropium and Albuterol-Insulin Glulisine (Vials)
- Ipratropium and Albuterol-Insulin glulisine Subcutaneous
- Ipratropium and Albuterol-Insulin human inhaled Inhalation